EPSTEIN-BARR VIRUS AND NASOPHARYNGEAL CARCINOMA: VIRAL MARKERS FOR DIAGNOSTICS AND ASSESSMENT OF CLINICAL STATUS OF PATIENTS

EPSTEIN-BARR VIRUS AND NASOPHARYNGEAL CARCINOMA: VIRAL MARKERS FOR DIAGNOSTICS AND ASSESSMENT OF CLINICAL STATUS OF PATIENTS

The etiological role of the Epstein-Barr virus (EBV) in the development of an undifferentiated histological variant of nasopharyngeal carcinoma (uNPC) found for the first time in regions with a high incidence of this pathology, the Southern provinces of China and the countries of Southeast Asia, and...

Full description

Bibliographic Details
Main Authors:	V. N. Kondratova, M. V. Lomaya, A. V. Ignatova, T. E. Dushenkina, K. V. Smirnova, A. M. Mudunov, A. V. Lichtenstein, V. E. Gurtsevitch, N. B. Senyuta
Format:	Article
Language:	English
Published:	Central Research Institute for Epidemiology 2018-04-01
Series:	Вопросы вирусологии
Subjects:	nasopharyngeal carcinoma epstein-barr virus serological markers
Online Access:	https://virusjour.crie.ru/jour/article/viewFile/189/99

Similar Items

EPSTEIN–BARR VIRUS IN THE POPULATION OF TWO GEOGRAPHICALLY DIFFERENT REGIONS OF RUSSIA
by: N. B. Senyuta, et al.
Published: (2017-03-01)

Diagnostic value of the Epstein-Barr virus serological markers in patients with nasopharyngeal carcinoma in cases of undetectable primary tumor location
by: V. E. Gurtsevitch, et al.
Published: (2016-10-01)

Diagnostic significance of DNA and antibodies against capsid antigens of anti-Epstein–Barr virus antibodies levels in blood plasma of nasopharyngeal carcinoma patients from non-endemic region
by: V. E. Gurtsevich, et al.
Published: (2015-06-01)

Markers of Epstein–Barr virus in clinical assessment of Russian patients with nasopharyngeal cancer
by: K. V. Smirnova, et al.
Published: (2021-11-01)

HLA II genes distribution in Epstein–Barr virus-associated nasopharyngeal carcinoma and other tumors of the oral cavity patients in Russia
by: N. B. Senyuta, et al.
Published: (2018-05-01)

Diagnostics of nasopharyngeal carcinoma with Epstein-Barr virus (<i>Herpesviridae</i>, <i>Lymphocryptovirus</i>, HHV-4) serological and molecular markers in cases of undetected primary tumor location
by: N. B. Senyuta, et al.
Published: (2019-10-01)

Monitoring the efficacy of conservative treatment of nasopharyngeal carcinoma by examining Epstein–Barr virus DNA titers in blood plasma (review)
by: D. A. Miroshnichenko, et al.
Published: (2020-11-01)

Molecular profile of Epstein–Barr virus in representatives of four ethnic groups of Russia: virus types, <i>LMP1</i> gene variability and malignancies
by: K. V. Smirnova, et al.
Published: (2023-12-01)

Epstein–Barr virus LMP1 oncogene polymorphism in tatar and slavic populations in Russian Federation impacting on some malignant tumours
by: V. E. Gurtsevitch, et al.
Published: (2020-05-01)

The role of Epstein–Barr virus in nasopharyngeal carcinoma
by: Zhi Yi Su, et al.
Published: (2023-02-01)

Epstein-Barr virus in Adygeans and Slavs in Russia: virus types, <i>LMP1</i> variants, and malignant tumors
by: K. V. Smirnova, et al.
Published: (2022-10-01)

Soro-epidemiologia do virus de Epstein-Barr (VEB) The seroepidemiology of the Epstein-Barr vírus (EBV)
by: Claudio Sergio Pannuti
Published: (1981-02-01)

Epstein–Barr virus (Herpesviridae: <i>Lymphocryptovirus</i>) types 1 and 2 and other viral markers in patients with nasopharyngeal carcinoma in two geographically and ethnically distinct regions of Russia
by: Ksenia V. Smirnova, et al.
Published: (2023-09-01)

Nasopharyngeal Carcinoma Progression: Accumulating Genomic Instability and Persistent Epstein–Barr Virus Infection
by: Xue Liu, et al.
Published: (2022-08-01)

Epstein–Barr virus in the ethnic Tatars population: the infection and sequence variants of LMP1 oncogene
by: K. V. Smirnova, et al.
Published: (2018-11-01)

Prognostic effect of residual plasma Epstein–Barr viral DNA after induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
by: Hua Zheng, et al.
Published: (2023-07-01)

Genotypic Characterization of Epstein Barr Virus in Blood of Patients with Suspected Nasopharyngeal Carcinoma in Ghana
by: Richmond Ayee, et al.
Published: (2020-07-01)

Smoking can increase nasopharyngeal carcinoma risk by repeatedly reactivating Epstein‐Barr Virus: An analysis of a prospective study in southern China
by: Ting Hu, et al.
Published: (2019-05-01)

Updates on Epstein–Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV
by: Naveed Ahmed, et al.
Published: (2022-12-01)

Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts
by: Po-Ju Lee, et al.
Published: (2022-08-01)

Individualized concurrent chemotherapy by pretreatment plasma Epstein‐Barr viral DNA in II‐III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort
by: Xue‐Song Sun, et al.
Published: (2019-08-01)

THE MODERN CONCEPTIONS ABOUT IMMUNOPATHOGENESIS OF INFECTION CAUSED BY THE EPSTEIN–BARR VIRUS
by: T. V. Goreiko, et al.
Published: (2014-06-01)

Molecular biological properties of the Эpstein-Barr virus LMP1 gene: structure, function and polymorphism
by: K. V. Smirnova, et al.
Published: (2015-06-01)

EPSTEIN-BARR VIRUS: CAUSES, CONSEQUENCES, DIAGNOSIS AND TREATMENT OF EPSTEIN-BARR VIRUS IN HUMAN
by: Koprivica Marko
Published: (2024-04-01)

Dynamic changes in plasma Epstein–Barr virus DNA load during treatment have prognostic value in nasopharyngeal carcinoma: a retrospective study
by: Sha‐Sha He, et al.
Published: (2018-04-01)

The Dietary Flavonol Kaempferol Inhibits Epstein–Barr Virus Reactivation in Nasopharyngeal Carcinoma Cells
by: Chung-Chun Wu, et al.
Published: (2022-11-01)

Associations between environmental factors and serological Epstein‐Barr virus antibodies in patients with nasopharyngeal carcinoma in South China
by: Ting Zhou, et al.
Published: (2019-08-01)

Do Epstein–Barr Virus Mutations and Natural Genome Sequence Variations Contribute to Disease?
by: Paul J. Farrell, et al.
Published: (2021-12-01)

Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinoma
by: Shuting Wu, et al.
Published: (2023-12-01)

Integration Profiling Between Plasma Lipidomics, Epstein–Barr Virus and Clinical Phenomes in Nasopharyngeal Carcinoma Patients
by: Yi Huang, et al.
Published: (2022-06-01)

Epstein-Barr Virus Infection in Children: Improving the Diagnosis and Treatment Program
by: E. N. Simovanyan, et al.
Published: (2016-04-01)

Ancient variants of the Epstein–Barr virus (Herpesviridae, Lymphocryptovirus, HHV-4): hypotheses and facts
by: Kseniya V. Smirnova, et al.
Published: (2020-05-01)

Enhancer infestation drives tumorigenic activation of inactive B compartment in Epstein-Barr virus-positive nasopharyngeal carcinomaResearch in context
by: Harue Mizokami, et al.
Published: (2024-04-01)

Genetic factors leading to chronic Epstein-Barr virus infection and nasopharyngeal carcinoma in South East China: Study design, methods and feasibility
by: Guo Xiu, et al.
Published: (2006-06-01)

Enhancer infestation drives tumorigenic activation of inactive B compartment in Epstein-Barr virus-positive nasopharyngeal carcinoma
by: Mizokami, Harue, et al.
Published: (2024)

Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma
by: Tomokazu Yoshizaki, et al.
Published: (2023-12-01)

Tonsillectomy in children with PFAPA-syndrome and Epstein-Barr viral infection
by: S. A. Levytska, et al.
Published: (2017-03-01)

Tonsillectomy in children with PFAPA-syndrome and Epstein-Barr viral infection
by: S. A. Levytska, et al.
Published: (2017-03-01)

Pathological features of the central nervous system lesions with Epstein-Barr virus in patients with HIV/AIDS
by: Kozko V.N., et al.
Published: (2013-12-01)

Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients
by: Yongqiao He, et al.
Published: (2021-08-01)